Back

Gut microbiota phospholipids regulate intestinal gene expression and can counteract the effects of antibiotic treatment

Zhang, X.-S.; Wang, Y.; Sun, H.; Zerbe, C.; Falcone, E.; Bhattacharya, S.; Zhang, M.; Gao, Z.; Diaz-Rubio, M. E.; Bharj, D.; Patel, D.; Pan, S.; Ro, G.; Grenard, J.; Armstrong, A.; Yin, Y. S.; Dominguez-Bello, M. G.; Holland, S.; Su, X.; Blaser, M. J.

2025-01-28 microbiology
10.1101/2025.01.28.633906 bioRxiv
Show abstract

The gut microbiome influences immune and metabolic homeostasis. Our research using non-obese diabetic (NOD) mice revealed that early-life antibiotic exposure remodels the gut microbiome affecting metabolism and accelerating type 1 diabetes (T1D) incidence, with cecal material transplant (CMT) mitigating the damage. Now examining murine intestinal lipidomic profiles, we identified 747 compounds. Comparing the lipidomic profiles of cecal contents of conventional and germ-free mice and their diets, we identified 87 microbially-produced lipids reduced by antibiotic exposure but CMT-restored. Parallel analysis of human fecal lipid profiles after azithromycin-exposure showed significant alterations with substantial overlap with mice. In vitro co-culture with mouse macrophages or small intestinal epithelial cells and human colonic epithelial cells identified phospholipids that repress inflammation through the NF{kappa}B pathway. Oral administration of these phospholipids to antibiotic-treated NOD mice reduced expression of ileal genes involved in early stages of T1D pathogenesis. These findings indicate potential therapeutic anti-inflammatory roles of microbially-produced lipids.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.